Third doses of SARS-CoV-2 vaccines in immunosuppressed patients with inflammatory bowel disease.
Lancet Gastroenterol Hepatol
; 6(12): 987-988, 2021 12.
Article
in English
| MEDLINE | ID: covidwho-1751536
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Immunization, Secondary
/
Immunocompromised Host
/
COVID-19 Vaccines
/
COVID-19
/
Immunosuppressive Agents
Type of study:
Prognostic study
Topics:
Long Covid
/
Vaccines
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Humans
/
Middle aged
/
Young adult
Country/Region as subject:
Europa
Language:
English
Journal:
Lancet Gastroenterol Hepatol
Year:
2021
Document Type:
Article
Affiliation country:
S2468-1253(21)00374-5
Similar
MEDLINE
...
LILACS
LIS